Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease

被引:0
|
作者
Preciado, Silvia [1 ,2 ,3 ]
Martinez-Villaluenga, Cristina [4 ]
Rico, Daniel [5 ]
Muntion, Sandra [1 ,2 ,3 ]
Garcia-Macias, Maria-Carmen [6 ,7 ]
Navarro-Bailon, Almudena [1 ,2 ,3 ]
Martin-Diana, Ana Belen [5 ]
Sanchez-Guijo, Fermin [1 ,2 ,3 ]
机构
[1] Univ Salamanca, Univ Hosp Salamanca, Inst Invest Biomed Salamanca IBSAL, Hematol Dept,Cell Therapy Unit, Salamanca 37007, Spain
[2] ISCIII, RICORS TERAV, Madrid 28029, Spain
[3] Ctr Red Med Regenerat & Terapia Celular Castilla &, Salamanca 37007, Spain
[4] CSIC, Inst Food Sci Technol & Nutr ICTAN, Jose Antonio Novais 10, Madrid 28040, Spain
[5] Agr Technol Inst Castilla & Leon ITACyL, Ctra Burgos Km 119, Valladolid 47071, Spain
[6] Univ Salamanca, Dept Med, Salamanca 37007, Spain
[7] Univ Salamanca, Canc Res Ctr, Salamanca 37007, Spain
关键词
wheat bran; ferulic acid; graft-versus-host disease; anti-inflammatory activity; immunomodulation; mouse model; MESENCHYMAL STEM-CELLS; PATHWAYS;
D O I
10.3390/nu15214582
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Graft-versus-host disease (GvHD) is a common and severe complication following allogeneic hematopoietic stem cell transplantation (HSCT). Its prevention and treatment is a major challenge. Ferulic acid (FA) has anti-inflammatory and antioxidant properties that could be attractive in this setting. Our aim was to evaluate a bioactive ingredient derived from wheat bran (WB), selected for its high concentration of FA, in a murine model of GvHD. The ingredient was obtained via a bioprocess involving hydrolysis and spray-drying. GvHD was induced via HSCT between MHC-mismatched mouse strains. FA treatment was administered orally. Survival and disease scores (weight loss, hunching, activity, fur texture, and skin integrity, each scored between 0 and 2 depending on disease severity) were recorded daily, histological evaluation was performed at the end of the experiment, and serum inflammatory cytokines were analyzed on days 9 and 28. Treatment with FA did not protect GvHD mice from death, nor did it diminish GvHD scores. However, histological analysis showed that ulcers with large areas of inflammatory cells, vessels, and keratin were less common in skin samples from FA-treated mice. Areas of intense inflammatory response were also seen in fewer small intestine samples from treated mice. In addition, a slight decrease in INF-gamma and TNF-alpha expression was observed in the serum of treated mice on day 28. The results showed some local effect of the ingredient intervention, but that the dose used may not be sufficient to control or reduce the inflammatory response at the systemic level in mice with GvHD. Higher dosages of FA may have an impact when evaluating the immunomodulatory capabilities of the hydrolyzed WB ingredient. Thus, further experiments and the use of technological strategies that enrich the ingredients in soluble ferulic acid to improve its efficacy in this setting are warranted.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Effects of Pravastatin on Murine Chronic Graft-Versus-Host Disease
    Yoon, Hyoung-Kyu
    Lim, Ji-Young
    Kim, Tae-Jung
    Cho, Chul-Soo
    Min, Chang-Ki
    TRANSPLANTATION, 2010, 90 (08) : 853 - 860
  • [2] The effects of mesenchymal stem cells in a murine sclerodermatous model of graft-versus-host disease
    Lim, Ji-Young
    Ryu, Da-Bin
    Lee, Sung-Eun
    Oh, Il-Hoan
    Min, Chang-Ki
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [3] Lacrimal gland involvement in graft-versus-host disease: A murine model
    Hassan, AS
    Clouthier, SG
    Ferrara, JLM
    Stepan, A
    Mian, SI
    Ahmad, AZ
    Elner, VM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46 (08) : 2692 - 2697
  • [4] MURINE CHRONIC GRAFT-VERSUS-HOST DISEASE AS A MODEL FOR LUPUS NEPHRITIS
    BRUIJN, JA
    VANELVEN, EH
    HOGENDOORN, PCW
    CORVER, WE
    HOEDEMAEKER, PJ
    FLEUREN, GJ
    AMERICAN JOURNAL OF PATHOLOGY, 1988, 130 (03): : 639 - 641
  • [5] The oxidative status of blood cells in a murine model of graft-versus-host disease
    Amer, Johnny
    Weiss, Lola
    Reich, Shoshana
    Shapira, Michael Y.
    Slavin, Shimon
    Fibach, Eitan
    ANNALS OF HEMATOLOGY, 2007, 86 (10) : 753 - 758
  • [6] The oxidative status of blood cells in a murine model of graft-versus-host disease
    Johnny Amer
    Lola Weiss
    Shoshana Reich
    Michael Y. Shapira
    Shimon Slavin
    Eitan Fibach
    Annals of Hematology, 2007, 86 : 753 - 758
  • [7] The Protection and Therapy Effects of Bortezomib in Murine Acute Graft-Versus-Host Disease
    Li, Z.
    Wu, Q.
    Yan, Z.
    Li, D.
    Lu, G.
    Mou, W.
    Wu, S.
    Pan, X.
    Lu, Q.
    Xu, K.
    TRANSPLANTATION PROCEEDINGS, 2013, 45 (06) : 2527 - 2535
  • [8] Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease
    Belle, Ludovic
    Fransolet, Gilles
    Somja, Joan
    Binsfeld, Marilene
    Delvenne, Philippe
    Drion, Pierre
    Hannon, Muriel
    Beguin, Yves
    Ehx, Gregory
    Baron, Frederic
    PLoS One, 2016, 11 (12):
  • [9] Genetic factors influencing the development of chronic graft-versus-host disease in a murine model
    DL Slayback
    JA Dobkins
    JM Harper
    RD Allen
    Bone Marrow Transplantation, 2000, 26 : 931 - 938
  • [10] Genetic factors influencing the development of chronic graft-versus-host disease in a murine model
    Slayback, DL
    Dobkins, JA
    Harper, JM
    Allen, RD
    BONE MARROW TRANSPLANTATION, 2000, 26 (09) : 931 - 938